Novartis AG Common Stock (NVS)
Stock-Based Compensation
$0.00
Quarterly · Period ending: · USD
NVS Stock-Based Compensation
Latest reported$0.00period ending
Latest reported$0.00period ending
NVS Quarterly Stock-Based Comp ($0.00 → $0.00)
Quarterly stock-based compensation
High-resolution chart · PNG
NVS stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 0 | |
| 303,000,000 | |
| 0 | |
| 268,000,000 | |
| 267,000,000 | |
| 262,000,000 | |
| 272,000,000 | |
| 255,000,000 | |
| 257,000,000 | |
| 260,000,000 | |
| 0 | |
| 0 | |
| 222,000,000 | |
| 190,000,000 | |
| 197,000,000 | |
| 208,000,000 | |
| 204,000,000 | |
| 203,000,000 | |
| 195,000,000 | |
| 173,000,000 | |
| 185,000,000 | |
| 183,000,000 | |
| 159,000,000 | |
| 202,000,000 | |
| 199,000,000 | |
| 178,000,000 | |
| 170,000,000 | |
| 216,000,000 | |
| 174,000,000 | |
| 198,000,000 | |
| 195,000,000 | |
| 169,000,000 | |
| 155,000,000 | |
| 182,000,000 | |
| 440,000,000 | |
| 169,000,000 | |
| 0 | |
| 0 | |
| 846,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 903,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,007,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 892,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 1,000,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |